Key Market Indicators
Romanian Pharmaceutical R&D Expenditure is projected to reach approximately $34 million PPP by 2028, up from around $33 million PPP in 2023. This marks an average annual growth rate of 0.3%. Since 2013, Romania's supply in this sector has increased at an average yearly rate of 9.5%. In 2023, Romania held the 16th spot in global rankings, with Norway surpassing it at roughly $33 million PPP. Leading the rankings, China, Germany, and South Korea secured the second, third, and fourth positions, respectively.
